Harmonized System
U.S. imports of Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale) (HS 300214) totaled $849.9M in August 2026, imported from 36 countries.
Importers of Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale) paid $735K in duties in August 2026, an average duty rate of 0.09% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule. Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale) imports of $849.9M in August 2026 ran 41% above the year-to-date monthly average of $601.8M.
Last updated: August 2026 dataBulk mixed immunological preparations — including those based on monoclonal antibodies — that have not yet been packaged into measured doses fall here, distinguishing them from retail-ready formulations. FDA's Center for Biologics Evaluation and Research (CBER) governs admissibility, and importers must ensure the foreign establishment holds the appropriate biologics license or operates under an FDA import authorization. Ireland and South Korea are the leading US suppliers under this heading, reflecting the concentration of large-scale biologics contract manufacturing in those markets. The US schedule separates monoclonal-antibody-containing products (3002140010) from other mixed immunological preparations (3002140090), a distinction that can affect both classification and FDA review pathways.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
688 import shipments a month
The key split is whether the mixed immunological product contains monoclonal antibodies (3002140010) versus other immunological mixtures (3002140090). Both require FDA CBER oversight, but monoclonal-antibody products may trigger additional biologics license application (BLA) review and distinct labeling requirements. Importers should confirm classification with a licensed customs broker before entry.
Importers generally need an FDA establishment registration for the foreign manufacturer, a valid biologics license or import authorization, a commercial invoice specifying the product's composition and intended use, and compliance with FDA's prior notice and entry filing requirements. Because admissibility rules are complex, consulting a licensed customs broker and regulatory counsel is strongly advised.
Trade Directory
List your company under HS 300214 — Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale), so the companies trading it can find you. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3002140010 | Immun Prod W Monoclonal Antibodies, Not for Retail | $788.6M | 0.05% | 0.33% | $433K |
| 3002140090 | Immunological Products, Mixed, Not for Retail Sale | $61.4M | 0.49% | 2.58% | $302K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3002140000 | Immunological Products, Mixed, N for Retail Sale | $758.7M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Subheading 2 of 10 in heading 3002
Subheading 300214 · $849.9M of $5.8B
ImportsExports
Imports
$849.9MYoY · free account
Exports
$758.7MYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $8.9B of Mixed Immunological Products, Not in Measured Doses (Not for Retail Sale) and exported $9.7B.
Through August 2026. Source: U.S. Census Bureau.
Imports · August 2026
origin
Singapore and South Korea together supply 72% of it.
customs district
destination
entry
rate provision · imports
99.5% enters free of duty; duty collected equals 0.09% of imports for consumption.